Trk C Receptor Signaling Regulates Cardiac Myocyte Proliferation during Early Heart Development in Vivo  by Lin, Michelle I et al.
Developmental Biology 226, 180–191 (2000)
doi:10.1006/dbio.2000.9850, available online at http://www.idealibrary.com onTrk C Receptor Signaling Regulates Cardiac
Myocyte Proliferation during Early
Heart Development in Vivo
Michelle I. Lin,* Indranil Das,* Gregory M. Schwartz,*
Pantelis Tsoulfas,† Takashi Mikawa,‡ and Barbara L. Hempstead*,1
*Department of Medicine and ‡Department of Cell Biology, Weill Medical College of Cornell
University, New York, New York 10021; and †The Miami Project, Department of Neurological
Surgery, University of Miami School of Medicine, Miami, Florida 33136
Neurotrophin-3 (NT-3) is a member of the neurotrophin family of growth factors, best characterized by its survival- and
differentiation-inducing effects on developing neurons bearing the trk C receptor tyrosine kinase. Through analysis of NT-3 and
trk C gene-targeted mice we have identified NT-3 as critically regulating cardiac septation, valvulogenesis, and conotruncal
formation. Although these defects could reflect cardiac neural crest dysfunction, the expression of NT-3 and trk C by cardiac
myocytes prior to neural crest migration prompted analysis of cell-autonomous actions of NT-3 on cardiac myocytes.
Retroviral-mediated overexpression of truncated trk C receptor lacking kinase activity was used to inhibit activation of trk C by
endogenous NT-3, during early heart development in ovo. During the first week of chicken development, expression of truncated
trk C reduced myocyte clone size by more than 60% of control clones. Direct mitogenic actions of NT-3 on embryonic cardiac
myocytes were demonstrated by analysis of BrdU incorporation or PCNA immunoreactivity in control and truncated trk
C-expressing clones. Inhibition of trk C signaling reduced cardiac myocyte proliferation during the first week of development, but
had no effect at later times. These studies demonstrate that endogenous NT-3:trk C signaling regulates cardiac myocyte
proliferation during cardiac looping and the establishment of ventricular trabeculation but that myocyte proliferation becomes
NT-3 independent during the second week of embryogenesis. © 2000 Academic Press
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The development of the functional heart depends upon
the coordinated growth, differentiation, migration, and
apoptosis of cell populations of diverse embryological ori-
gins. The cardiac myocyte plays a central role in this
process, beginning with commitment to a myocyte lineage
and acquisition of a rhythmically contractile phenotype. In
the well-studied chick model, cardiac myocytes actively
proliferate in the ventricular walls early in development
during ventricular trabeculation, forming a contractile lat-
tice within the ventricular chambers. Subsequently, the
outer myocardial layer thickens, giving rise to the compact
1 To whom correspondence should be addressed at the Weill
Medical College of Cornell University, Room C-606, 1300 York
Avenue, New York, NY 10021. Fax: (212) 746-8647. E-mail:pblhempst@mail.med.cornell.edu.
180one, which generates the outer wall of the ventricular
hambers. In later embryogenesis, the mitotic activity of
ardiac myocytes slows and is lost soon after birth (Clark
nd Fischman, 1983).
Few growth factors which directly regulate cardiac myo-
yte proliferation have been identified despite the identifi-
ation of gene-targeted mouse models with abnormalities
n ventricular morphogenesis and in vitro studies. The
euregulins and cardiotrophin-1 were first hypothesized to
egulate myocyte proliferation based on the prominent
entricular phenotypes of gene-targeted mice (Gassmann et
l., 1995; Meyer and Birchmeier, 1995; Wollert and Chien,
997). However, these factors demonstrate primarily hyper-
rophic and survival activities on cultured neonatal rodent
ardiac myocytes (Ford et al., 1999; Latchman, 2000; Zhao
t al., 1998). More recently, retinoic acid and erythropoietin
ave been postulated to act indirectly to promote myocyte
roliferation (Tran and Sucov, 1998; Wu et al., 1999). The
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181Trk C Receptor Signaling in Myocyte Proliferationbest characterized mitogenic factors, however, are members
of the fibroblast growth factor (FGF) family, specifically
FGF-1, -2, and -4. The FGFs induce cardiac myocyte prolif-
eration in vitro (Zhu et al., 1996) and inhibition of FGF
receptor signaling in vivo decreases myocyte proliferation
during early embryogenesis in the chick (Mima et al., 1995).
Our identification of abnormal cardiac morphogenesis
leading to the early postnatal lethality in mice with de-
creased neurotrophin-3 expression (Donovan et al., 1996)
prompted an evaluation of direct actions of this growth
factor on embryonic cardiac myocytes. The neurotrophins
are a family of polypeptide growth factors including nerve
growth factor (NGF), brain-derived neurotrophic factor
(BDNF), and neurotrophins 3 and 4/5 (NT-3 and NT-4/5),
which have been best characterized for their critical roles in
neuronal differentiation and survival (Snider, 1994). The
neurotrophins mediate their actions by binding to the trk
family of receptor tyrosine kinases, with NGF binding to
trk A, BDNF and NT-4/5 to trk B, and NT-3 to trk C. NT-3
binding results in trk C kinase activation, leading to the
recruitment and phosphorylation of signaling proteins
which regulate neuronal proliferation, differentiation, and
survival. In addition, alternative splicing of the trk C gene
can generate truncated trk C isoforms which lack the
kinase domain (Garner and Large, 1994; Tsoulfas et al.,
1993; Valenzuela et al., 1993). These noncatalytic receptors,
which are well conserved among species, inhibit signaling
by catalytic receptors when both catalytic and truncated
isoforms are coexpressed (Das et al., 2000). Indeed, overex-
pression of truncated trk C in a transgenic mouse model
leads to a phenotype similar to that observed in trk C or
NT-3 null mutant animals, suggesting that the truncated
trk C receptors negatively modulate signaling by kinase
active trk C (Palko et al., 1999).
Although trk C is highly expressed by neurons, it is also
expressed in muscle, lung, kidney, heart, and vascular
smooth muscle cells (Donovan et al., 1995; Tessarollo et
al., 1993) where its biological actions are unclear. We have
recently localized trk C expression to mouse embryonic
cardiac myocytes and have demonstrated that NT-3 and trk
C critically regulate cardiac morphogenesis, with NT-3
(2/2) and trk C (2/2) animals exhibiting ventricular septal
defects, delay in conotruncal septation and rotation, and
valvular defects (Donovan et al., 1996; Tessarollo et al.,
1997). Since the septation of the outflow tracts and valvular
morphogenesis are influenced, in part, by cardiac neural
crest, this constellation of defects might reflect impaired
neural crest migration, proliferation, or survival. However,
the early expression of trk C by cardiac myocytes prompted
investigation of potential direct actions of NT-3 in cardiac
myocyte development. Thus, we have utilized retroviral
gene delivery to alter NT-3 signaling by cardiac myocytes
during the first week of avian development. Replication-
deficient recombinant retrovirus encoding the chicken
truncated trk C receptor was delivered to the developing
heart to inhibit NT-3-dependent trk C activation. Using
clonal analysis, these in vivo studies have allowed us to (
Copyright © 2000 by Academic Press. All rightassess the stage-specific effects of the impaired NT-3 sig-
naling on cardiac myocyte proliferation, migration, and
survival.
MATERIAL AND METHODS
Retroviral vectors. The pCXIZ retrovirus is a replication-
defective variant based on the spleen necrosis virus (Mikawa and
Fischman, 1992), which utilizes an internal ribosome entry se-
quence (IRES) genome upstream of the bacterial b-galactosidase
b-gal) gene to identify cells expressing viral transgenes. The cDNA
for chicken truncated trk C corresponds to the kinase-deleted
isoform (Garner and Large, 1994). Sequences from 215 to 1598,
which includes the entire cDNA and 15 and 8 bases upstream and
downstream, respectively, were subcloned upstream of the IRES,
and the resulting vector was designated trunc C. Following cotrans-
fection of the packaging line ND17.2G with the trunc C vector and
pMEX neo, stable clones were isolated following selection in G418
as described (Mikawa and Fischman, 1992). Cells from single
colonies were subjected to cloning by limiting dilution for three
successive rounds to establish clonal lines with titers of 4–8 3 104
virions/ml. Infection of chick embryo fibroblasts was performed to
document viral titer and to confirm the absence of helper virus
(Mikawa et al., 1991). The retrovirus CXL (Mikawa and Fischman,
1992), expressing only cytoplasmically localized b-gal, was used as
a control.
In ovo infection. Concentrated viral solutions (.106 virions/
ml) of 5–10 nl, containing Polybrene (100 mg/ml), were pressure
injected into the myocardial wall of chick hearts at embryonic day
2, 3, or 5 (E2, E3, E5), using a Picospritzer II (General Valve, NJ) and
a Leitz micromanipulator (No. 031626). Eggs were resealed with
Parafilm and embryos were returned to a humidified incubator at
37.5°C for further development. Selected embryos were pulse-
labeled with BrdU by injecting BrdU (Amersham), 75 mg for E5 and
E6 or 150 mg for E9 embryos, onto the amniotic membrane for 5 h
prior to embryo harvest.
Morphologic analysis. Infected embryos were fixed by immer-
sion overnight at 4°C in phosphate-buffered saline (PBS) containing
2% paraformaldehyde and processed for 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside (X-gal; Gold Biotechnology, Inc.) his-
ochemistry, in whole mount as described (Mikawa et al., 1992a).
earts exhibiting b-gal-positive colonies were embedded in Para-
last (Oxford Labware), serially sectioned at 10 mm thickness, and
examined following counterstaining with eosin.
Analysis of truncated trk C expression. ND17.2G clones sta-
bly transfected with the trunc C pCXIZ vector were lysed in RIPA
buffer containing the protease inhibitors as described (Mahadeo et
al., 1994). Lysates containing equivalent amounts of protein were
separated by SDS–PAGE and transferred to nitrocellulose. Western
blot analysis was performed using a polyclonal antisera specific for
a unique sequence in the cytoplasmic tail of the truncated trk C
isoform (Donovan et al., 1995; Tsoulfas et al., 1993).
To confirm NT-3 binding to truncated trk C, NT-3 (human
ecombinant; Promega, Madison, WI) was radioiodinated using
actoperoxidase as described (Hempstead et al., 1989) to a specific
ctivity of 2500 cpm/fmol. The ND17.2G expressing truncated trk
(trunc C) or parental ND17.2G cells (1 3 106 cells/ml) were
incubated with 125I-NT-3 (50 ng/ml) for 2 h at 4°C as described
Kaplan et al., 1991). Bound NT-3 was crosslinked to cells by
xposure to 50 mM N-hydroxysuccinimidyl-4-azido benzoate
HSAB) (Pierce, Rockford, IL) for 10 min with photoactivation using
s of reproduction in any form reserved.
182 Lin et al.FIG. 1. Expression of NT-3, trk C, and truncated trk C in the avian heart during looping (HH stage 17). Immunohistochemical detection
of NT-3, full-length trk C, and truncated trk C expression patterns in sections of chick heart at E 2.5. Heart sections were incubated with
anti-full-length trk C antiserum (A–C), anti-NT-3 antiserum (D–F), anti-truncated trk C antiserum (G), or preimmune serum as a control
for the truncated trk C antisera (H), preimmune serum as the trk C antiserum control (I), or anti-NT-3 preincubated with the immunizing
peptide (J). The positions of higher magnification views (B, C, E, F) are indicated on lower magnification views (A, D). Immunoreactive
products were visualized with VIP as the chromogenic substrate (red reaction product). a, atrium; v, ventricle; closed arrow, epicardium;
open arrow, endocardium. (A and D, original magnification 403; B, E, G, H, I, and J, 4003; C, F, 6003).
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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183Trk C Receptor Signaling in Myocyte Proliferationa 365-nm UV lamp. Cells were washed twice in 50 mM lysine in
PBS to quench the HSAB and lysed in RIPA buffer containing
protease inhibitors. Proteins were separated by SDS–PAGE and
autoradiography was performed as described (Hempstead et al.,
1991).
Immunohistochemical analysis. Immunohistochemistry to
evaluate expression of NT-3, kinase-active trk C, or truncated trk
C in uninfected chick embryos was performed using dissected
tissues from embryos at E3, E6, and E9, which were fixed for 2 h in
0.1% paraformaldehyde in PBS. Cryoprotected tissues were sec-
tioned at 10 mm and incubated with rabbit polyclonal antiserum
specific for NT-3 (1:200) (sc-547; Santa Cruz), rabbit polyclonal
antiserum specific for kinase active trk C (Donovan et al., 1995)
generated using the peptide LVDGQPRQAKGELGL, used at
FIG. 3. Expression of NT-3, trk C, and truncated trk C in the avia
full-length trk C, and truncated trk C expression patterns in
anti-full-length trk C antiserum (A, B), anti-NT-3 antiserum (C, D
for the truncated trk C antiserum (F), preimmune serum as the trk C
peptide (H). Immunoreactive products were visualized with VIP as t
(A and C, original magnification 403; B, D, E, F, G, and H, 4003).
FIG. 2. Expression of NT-3, trk C, and truncated trk C in the
Immunohistochemical detection of NT-3, full-length trk C, and tru
sections were incubated with anti-full-length trk C antiserum (A–C
serum as a control for the truncated trk C antiserum (H), preimmu
with the immunizing peptide (J). The positions of higher magnificat
Immunoreactive products were visualized with VIP as the chrom
arrow, endocardium. (A and D, original Magnification 403; B, E, G, H,
Copyright © 2000 by Academic Press. All right:200), or rabbit polyclonal antiserum specific for truncated trk C
Donovan et al., 1995) (generated using the peptide LNPISLPGHS-
PLNQG, a unique sequence in the cytoplasmic tail of the trun-
ated trk C isoform, at 1:200 dilution). Following washing, sections
ere incubated with biotinylated anti-rabbit antibody and immu-
oreactivity was detected using VIP substrate (Vector Laboratories)
fter ABC signal amplification (Vector Laboratories). Preincubation
f antiserum with the immunizing peptide was used to confirm
ntibody specificity. In addition, these antisera have been utilized
n NT-3 or trk C gene-targeted mouse tissues and a lack of
mmunoreactivity has been confirmed.
Immunohistochemistry was performed on tissue sections from
nfected embryos using the polyclonal antiserum recognizing trun-
ated trk C (1:500) (Donovan et al., 1995) and a monoclonal
art at HH stage 35 (E9). Immunohistochemical detection of NT-3,
ons of chick heart at E9. Heart sections were incubated with
i-truncated trk C antiserum (E), or preimmune serum as a control
serum control (G), or anti-NT-3 preincubated with the immunizing
romogenic substrate (red reaction product). a, atrium; v, ventricle.
n heart during septation and trabeculation at HH stage 28 (E6).
ed trk C expression patterns in sections of chick heart at E6. Heart
ti-NT-3 (D–F), anti-truncated trk C antiserum (G), or preimmune
rum as the trk C antiserum control (I), or anti-NT-3 preincubated
iews (B, C, E, F) are indicated on lower magnification views (A, D).
ic substrate (red reaction product). a, atrium; v, ventricle; closedn he
secti
), ant
anti
he chavia
ncat
), an
ne se
ion v
ogenI, and J, 4003; C, F, 6003).
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184 Lin et al.antiserum to b-galactosidase (1:500; Sigma Chemical Co., St. Louis,
O). Embryonic chick tissue was fixed in 2% paraformaldehyde in
BS and cryoprotected prior to frozen sectioning at 10 mm. Sections
were blocked with 0.1% Triton X-100 in 5% normal goat serum in
PBS prior to antibody addition. Following washing, sections were
incubated with fluorescein-labeled goat anti-mouse or Texas red-
labeled goat anti-rabbit antisera (each at 1:200), prior to washing
and analysis using a Nikon epifluorescence microscope.
BrdU histochemistry was performed on paraffin-embedded sec-
tions treated with 0.1% hydrogen peroxide in methanol (220°C),
permeabilized with proteinase K (10 mg/ml), treated with 2 N HCl,
nd neutralized in 0.1 M Borax, pH 9.6, as per the commercial
rotocol. Sections were incubated with the monoclonal a-BrdU
antiserum overnight at 4°C (1:500) (Dako A/S Denmark). Following
washing, immune complexes were visualized using biotinylated
anti-mouse IgG at 1:200 (Vector Laboratories) and the Vectastain
Elite ABC Kit followed by the VIP substrate (Vector Laboratories).
TUNEL procedure was performed as per the manufacturer’s
recommendation (Roche Molecular Biochemicals) using frozen
sections at 10 mm. Double-immunofluorescence detection of
UNEL and b-gal reactivity was visualized using a Zeiss Axioskop
icroscope.
Immunohistochemical detection of proliferating cell nuclear
ntigen (PCNA) was performed on embryonic hearts treated with
-gal prior to paraffin embedding. Deparaffinized sections were
reated with proteinase K (10 mg/ml) for 15 min followed by
treatment with Target Unmasking Fluid (Signet) as per the manu-
facturer’s protocol, prior to incubation with the monoclonal anti-
PCNA antibody (Dako) at 1:500. After washing, immune com-
FIG. 4. Expression of truncated trk C by the transfected packaging
cell line. (A) Western blots of cell lysates of parental (con) or two
independent truncated trk C (trunc trk C)-expressing packaging cell
lines were probed with truncated trk C antiserum. Results obtained
using two independent lines stably expressing truncated trk C are
shown. Expression of the truncated trk C receptor was observed at
110 kDa. (B) NT-3 binding to truncated trk C was detected by
crosslinking. Two independent lines stably expressing truncated
trk C and the control parent cell line were incubated with 125I-NT-3
following which bound NT-3 was crosslinked to cells using HSAB.
Following detergent lysis, proteins were separated by SDS–PAGE
and autoradiography was performed. The molecular size of the
120-kDa crosslinked species is consistent with the predicted mo-
lecular weight of the NT-3 and truncated trk C product (13 plus 110
kDa).plexes were visualized using biotinylated anti-mouse 1gG at 1:200
Copyright © 2000 by Academic Press. All right(Vector Laboratories) and the Vectastain Elite ABC Kit, followed by
the VIP substrate (Vector Laboratories).
RESULTS
NT-3 and Kinase-Active Trk C Are Coexpressed by
Cardiac Myocytes
To identify potential actions of NT-3 on cardiac morpho-
genesis, the expression of NT-3 and trk C in the developing
heart was examined by immunohistochemical localization
from HH stage 17 to 35. This time frame was chosen as it
encompasses many of the major morphogenetic events,
with the completion of cardiac looping (at HH 17, or
approximately E2.5), the establishment of ventricular tra-
beculae (from HH stage 18 to stage 30), and cardiac septa-
tion (at HH 23–35) (Sissman, 1970). At HH stage 17, both
kinase-active trk C and NT-3 are expressed by cardiac
myocytes within regions of the looping heart which will
develop into atria or ventricles (Figs. 1A–1F). Coexpression
of ligand and catalytically active receptor is most promi-
nent in embryonic myocytes, with little immunoreactivity
of epicardial and endocardial cells (Figs. 1B, 1C, 1E, and 1F).
Truncated trk C expression is not detectable in the devel-
oping heart at this stage (Fig. 1G).
In ventricles with a well-established trabecular lattice
(HH 28, E6), expression of both NT-3 and trk C is regionally
localized to myocytes within the trabeculations, whereas
expression by subepicardial myocytes is diminished (Figs.
2A–2F). Myocytes within all four chambers of the heart
exhibited similar levels of expression of NT-3 and trk C
(Figs. 2A and 2D and data not shown). NT-3 and kinase-
active trk C, however, are not expressed by cells within the
endocardial cushions or by the endocardium (Figs. 2A, 2C,
2D, and 2F). No truncated trk C expression is noted in the
heart at E6 (Fig. 2G). By E9 (HH stage 35), when the
ventricular wall consists of a well-defined proliferating
compact zone and less mitotically active trabeculations
(Jeter and Cameron, 1971), expression of both ligand and
receptor is further diminished (Figs. 3A–3D), and cardiac
myocytes fail to express NT-3 or catalytically active trk C
at later developmental stages. No expression of the trun-
cated trk C isoform was detected in hearts examined at E9
(Fig. 3E).
Generation of Stable Truncated Trk C Viral-
Producing Lines
To assess the role of NT-3 in modulating the early stages
of chick heart development in ovo, a replication-defective
retrovirus encoding truncated chick trk C was generated.
Transfection of this viral vector encoding lacZ into a
packaging cell line resulted in stable clones from which the
virus was propagated at high titer. Expression of truncated
trk C in these clones was confirmed by Western blot
analysis, which demonstrated a prominent 100-kDa band
corresponding to the predicted molecular size of truncated
s of reproduction in any form reserved.
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185Trk C Receptor Signaling in Myocyte Proliferationtrk C, and was absent in blots of parental packaging cells
(Fig. 4A). To confirm that truncated trk C expressed by
these clones was capable of binding NT-3, crosslinking
analysis was performed using the radioiodinated ligand (Fig.
4B). The crosslinked product of approximately 120 kDa,
composed of NT-3 (13.5 kDa) and truncated trk C (110
kDa), was detected in clones expressing the truncated trk C
retrovirus, but not in parental packaging cells.
Expression of Truncated Trk C Reduces Myocyte
Clone Size
Prior studies have demonstrated that the truncated trk C
receptor can inhibit NT-3 signaling when coexpressed with
kinase-active trk C (Das et al., 2000; Palko et al., 1999). To
nalyze the effects of truncated trk C overexpression on
ardiac morphogenesis, in ovo injections of 10–100 viral
particles into the developing ventricle were performed at
E3. Following retroviral infection and integration into the
host genome, the truncated trk C transgene and the reporter
gene b-galactosidase are transcribed as a dicistronic mes-
sage utilizing an IRES sequence. Since the expression of
b-galactosidase, translated in a 59 cap-independent manner
ia the IRES element, serves as a marker for truncated trk C
xpression in virally infected cells, double immunofluores-
ence labeling of cells was performed to assess the coordi-
ate expression of truncated trk C and b-galactosidase.
Sections of E7 chick ventricle, obtained following infection
at E3 with the truncated trk C/b-galactosidase-encoding
irus, demonstrate that the immunolocalization of trun-
ated trk C coincides with localization of b-galactosidase
(Figs. 5A and 5B).
To assess the effects of truncated trk C expression on
cardiac myocyte clone size, embryos were injected in the
developing ventricular wall at E3 with retrovirus at low
viral titers (105–106 virions/ml) to obtain spatially isolated
olonies of cells at E7, as visualized by X-gal histochemis-
ry. From inspection of intact hearts, clones from embryos
xpressing truncated trk C appeared smaller than clones
rom embryos infected with control lacZ virus (Figs. 6A and
B). In analysis of serial sections from E7 ventricles infected
ith either control lacZ virus or truncated trk C virus,
olonies generated from cells expressing control virus dem-
nstrate labeled cells distributed from the subepicardial
urface to the trabeculations (Fig. 6C). The distribution of
abeled cells is consistent with formation of cone-shaped
lones arising from infection of a single myocyte at E3
Mikawa et al., 1992b). Colonies generated from cells ex-
ressing truncated trk C were of smaller size (Fig. 6D).
owever, truncated trk C-expressing myocytes were
resent both in the subepicardial region of the ventricular
all and within the trabeculae, suggesting that overexpres-
ion of truncated trk C does not alter the migration of
yocytes, from subepicardially located progenitors to
aughter cells located nearer to the ventricular lumen.
nalysis of 6 ventricular clones from control lacZ-infected
mbryos or 18 ventricular clones from truncated trk
Copyright © 2000 by Academic Press. All right-infected embryos demonstrated an average of 39 myo-
ytes in control clones and 14 cells in truncated trk C
xpression clones, resulting in a 63% decrease in the size of
yocyte clones in which trk C signaling was disrupted (P ,
.001, unpaired two-tailed t test) (Figs. 6E and 6F). Clones
xpressing truncated trk C in either the left or the right
entricle exhibited similar decreases in clonal size, com-
ared to similarly positioned control lacZ-infected clones,
uggesting that the effects of NT-3 signaling in the devel-
ping right or left ventricle were similar.
Expression of Truncated Trk C Reduces Cell
Proliferation
The reduction in the size of truncated trk C-expressing
clones suggests that NT-3-mediated trk C signaling could
induce proliferation of progenitor cells or inhibit apoptosis.
To determine if a dominant effect of NT-3 is to regulate
cellular proliferation, BrdU incorporation was assessed in
ventricles which had been infected with control or trun-
cated trk C retrovirus at E2, E3, or E5. BrdU labeling of
embryos was performed for 5 h prior to embryo harvest, at
3 to 4 days following injection as indicated (Fig. 7). The
percentage of b-galactosidase-positive cells which exhibited
nuclear BrdU uptake was assessed in embryos (E6) express-
ing either control or truncated trk C (Figs. 7A and 7B).
Myocytes infected with control lacZ virus exhibited high
levels of BrdU uptake at E5 (44%), with progressive de-
creases at E6 (39%) and E9 (25%) (Fig. 7C). These values are
consistent with prior studies demonstrating rapid myocyte
proliferation at the earlier developmental stages, with a
gradual reduction in proliferation rate at later stages, as
assessed by mean doubling times (Mima et al., 1995) or
tritiated thymidine labeling (Jeter and Cameron, 1971;
Clark and Fischman, 1983). However, the percentage of
BrdU-positive cells in truncated trk C-expressing clones
was significantly reduced compared to control
b-galactosidase-expressing clones at E5 (28% of trunc trk C
clones vs 44% in control clones, P , 0.005, unpaired
two-tailed t test) and at E6 (26% in trunc trk C clones vs
9% in control clones, P , 0.01, unpaired two-tailed t-test)
(Fig. 7C). Thus, at E5 and E6, expression of truncated trk C
resulted in a 34–36% reduction in BrdU incorporation
compared to control viral-infected myocytes. However, by
E9 no significant differences in the percentage of BrdU-
positive cells were detected in truncated trk C or control-
injected myocytes (22% of trunc trk C clones vs 25% of
control clones), suggesting that trk C signaling regulates
cardiac myocyte proliferation during the first week of
embryogenesis, but has little effect at later developmental
times.
As independent confirmation that truncated trk C expres-
sion reduces myocyte proliferation, PCNA immunoreactiv-
ity was quantitated in embryos infected with either control
or truncated trk C virus at E3 and harvested at E6. The
percentage of PCNA-positive cells in truncated trk
C-expressing clones was significantly reduced compared to
s of reproduction in any form reserved.
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186 Lin et al.FIG. 5. Double immunolabeling of b-galactosidase and truncated trk C in chick embryonic heart. Double immunofluorescence labeling
was performed to document the coexpression of truncated trk C and b-galactosidase in chick hearts injected with the retroviral vector
encoding both genes. Embryos were injected at E3 and incubated until sacrifice at E7. Immunohistochemistry was performed using mouse
anti-b-galactosidase antibody with a fluorescein-conjugated secondary antibody (A) and a rabbit anti-truncated trk C antibody with a Texas
red-conjugated secondary antibody (B). Note the colocalization of both b-galactosidase and truncated trk C in virally infected myocytes.
Sections stained with only one primary and secondary antibody exhibited no signal in the other channel, indicating the absence of
cross-contamination of signal. (A and B, original magnification 4003).
FIG. 6. Expression of truncated trk C results in reduced clone size in E7 chick embryonic hearts by whole-mount and histological
analyses. Chick embryos are injected with either the control virus (vector encoding b-galactosidase gene alone, A and C) or the trunc trk
C virus (vector encoding both b-galactosidase and truncated trk C genes, B and D) at E3 and harvested at E7. Following fixation in
araformaldehyde, hearts were treated with X-gal to generate a blue precipitate in b-galactosidase-expressing cells. The hearts were
subsequently sectioned, counterstained with eosin, and analyzed microscopically. The size of each clone was determined by counting the
number of b-gal-positive cells in serial sections and tabulated as individual clone counts (E) or as average clone size (F). Overexpression of
runcated trk C results in a 63% reduction in average clone size compared to control clones. e, epicardium; l, lumen of ventricle. (A and
, original magnification 353; C and D, 4003)
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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188 Lin et al.control b-galactosidase-expressing clones at E6 (35% of
trunc trk C clones vs 48% of control clones, P , 0.02,
npaired two-tailed t test) (Fig. 7D).
The reduction in BrdU incorporation and reduction in
CNA immunoreactivity upon truncated trk C expression
t both E5 and E6 suggest that cumulative antiproliferative
ffects of truncated trk C expression can result in the 63%
eduction in myocyte clone size observed at E7. However,
o formally exclude an apoptotic effect upon truncated trk
expression, TUNEL analysis was performed on embry-
nic hearts at E5, E6, or E7 following retroviral infection
ith lacZ or truncated trk C virus at E3. Embryos had
dditionally been pulse-labeled with BrdU for 5 h prior to
mbryo harvest, so that BrdU incorporation and TUNEL
nalysis could be directly compared. Consistent with the
esults obtained at E5 and E6, truncated trk C-expressing
yocytes demonstrated reduced BrdU incorporation com-
ared to control viral-infected myocytes at E7 (39% BrdU
ncorporation in control myocytes, 25% BrdU incorpora-
ion in truncated trk C myocytes, yielding a 35% reduction
n BrdU incorporation) (Fig. 8C). However, upon concomi-
ant immunofluorescence localization of b-galac-
osidase and TUNEL reactivity, less than 1% of the
b-galactosidase-expressing cells exhibited TUNEL positiv-
ity in embryos infected with either control or truncated trk
C virus (Figs. 8A and 8B). Indeed, TUNEL analysis at E5 or
E6 of embryos injected with either CXL or truncated trk C
virus also yielded less that 1% of the b-galactosidase-
expressing cells exhibiting TUNEL reactivity (the ratio of
FIG. 7. Expression of truncated trk C results in reduced BrdU in
injected with the control or truncated trk C-expressing virus at E2,
E6, or E9, respectively. Following harvesting of chick hearts
incorporation was performed on heart sections (A, hearts injected w
at E3 and harvested at E6). (C) Sections were analyzed for the perce
uptake, with intense purple staining within the b-galactosidase-po
nalyzed in each embryo, and the percentage of b-galactosidase
determined for each embryo. For E2 to E5 analysis, five CXL- and fi
E5 to E9 analysis, three CXL- and three truncated trk C-injected
averaged for each time point, with the means and standard errors of
data obtained with CXL-infected hearts and the open columns rep
were analyzed for the percentage of b-galactosidase-expressing cells
ithin the b-galactosidase-positive blue cell. 150 to 400 b-galactos
of b-galactosidase-positive cells which exhibited nuclear PCNA im
each embryo were averaged, with the means and standard errors of t
obtained with control virus, open columns with trunc trk C virus
4003).
FIG. 8. Expression of truncated trk C does not induce cardiac my
irus or trunc trk C-expressing virus at E3 and were pulsed with B
b-galactosidase immunolocalization were performed concomitant
positive cells and rhodamine-conjugated antiserum to detect b
ouble-positive cells to b-galactosidase-positive cells is noted belo
xamined per condition. (A) Embryos infected with control virus; (
or the percentage of b-galactosidase-expressing cells which exh
b-galactosidase-positive cells were analyzed per condition. The fill
open columns represent data obtained with trunc trk C-infected hearts
Copyright © 2000 by Academic Press. All rightTUNEL/b-gal double-positive cells to b-gal-positive cells at
E5 was 1/124 in control virus-infected hearts, 1/198 in
trunc trk C-infected hearts and at E6 was 5/568 in control
virus-infected hearts and 3/380 in trunc trk C-infected
hearts). These results suggest that the dominant action of
NT-3 on embryonic cardiac myocytes is to induce cell
proliferation.
DISCUSSION
NT-3 Is a Physiological Mitogen for Cardiac
Myocytes
By utilizing retroviral gene delivery to inhibit NT-3-
dependent trk C signaling, our studies establish that NT-3
is a potent physiologic mitogen for embryonic ventricular
cardiac myocytes. These studies identify NT-3 as one of a
small number of growth factors regulating cardiac myocyte
proliferation during early development. Indeed, only FGF
receptor signaling, most likely initiated by FGF-2 and
FGF-4, has been demonstrated to induce cardiac myocyte
proliferation during the rapid phase of ventricular wall
growth in the first week of chick development (Zhu et al.,
1996; Mima et al., 1995). The observed inability to com-
pletely suppress myocyte proliferation during cardiac
chamber formation by inhibiting either FGF receptor sig-
naling (Mima et al., 1995) or trk C receptor signaling
suggests that both growth factors may act at a similar
developmental stage to regulate myocyte proliferation.
oration in E5 and E6, but not in E9, chick hearts. Embryos were
r E5 and subjected to BrdU pulse for 5–6 h prior to sacrifice at E5,
development in X-gal, immunohistochemical analysis of BrdU
CXL at E3 and harvested at E6; B, hearts injected with trunc trk C
of b-galactosidase-expressing cells which exhibited nuclear BrdU
e blue cell (arrow). 150 to 400 b-galactosidase-positive cells were
tive cells which exhibited nuclear BrdU immunoreactivity was
uncated trk C-injected hearts were examined. For E3 to E6 and for
ts were examined. The results obtained with each embryo were
ean represented graphically, with the filled columns representing
ting data obtained with trunc trk C-infected hearts. (D) Sections
h exhibited PCNA immunoreactivity, with intense purple staining
-positive cells were analyzed in each embryo, and the percentage
reactivity was determined for each embryo. Results obtained with
ean represented graphically, with filled columns representing data
picardium; l, lumen of ventricle. (A and B, original magnification
apoptosis in E7 chick hearts. Embryos were injected with control
for 5 h prior to harvesting at E7. (A and B) TUNEL reactivity and
heart sections using fluoresceinated dUTPs to detect TUNEL-
ctosidase-expressing cells. The ratio of TUNEL/b-galactosidase
ch image and is representative of results obtained in two embryos
bryos infected with trunc trk C virus. (C) Sections were analyzed
d nuclear BrdU uptake, as described in Fig. 7. More than 500
lumns represent data obtained with CXL-infected hearts, and thecorp
E3, o
and
ith
ntage
sitiv
-posi
ve tr
hear
the m
resen
whic
idase
muno
he m
. e, e
ocyte
rdU
ly on
-gala
w ea
B) em
ibite
ed co. e, epicardium. (A and B, original magnification 4003).
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189Trk C Receptor Signaling in Myocyte ProliferationIndeed, a stage-by-stage comparison of NT-3:trk C local-
ization (this study) with FGF-1, -4:FGFR1 localization in
developing chick hearts (Consigli and Joseph-Silverstein,
1991; Sugi et al., 1995; Zhu et al., 1996) suggests that both
NT-3 and FGFs may act upon myocytes of the looping heart
(stages 14–17, E2–2.5) to regulate proliferation. However, by
stage 24–32 (E4.5–7.5) when ventricular trabeculation is
well established, the patterns of expression of the two
ligand:receptor systems are distinct and reciprocal; NT-3/
trk C expression is prominent within the trabeculae, and
diminishing in the compact zone, whereas FGF/FGFR1
expression is reduced in the trabeculae, but more promi-
nent in the compact zone. These observations suggest that
both FGFs and NT-3 may regulate mitogenesis from E2 to
E5 during the transition from a looping heart to a heart with
established trabeculations. From E4.5 to E7.5, FGF signal-
ing may act to promote the continued proliferation of
myocytes within the developing compact zone, while NT-3
regulates the significant proliferation of myocytes within
the developing trabeculae, where continued BrdU uptake is
readily detectable (Fig. 7). Given the temporally overlapping
expression of FGFR and trk C receptor in ventricular
myocytes, it will be important in future studies to deter-
mine if these growth factors act in a complementary man-
ner in the looping heart and in a spatially restricted manner
upon cardiac myocytes of the trabecular wall.
Other growth factors which have been postulated to
regulate myocyte proliferation include the insulin-like
growth factors, neuregulin, and cardiotrophin-1. Prior in
itro studies have documented that insulin-like growth
actors (IGF-1 and IGF-2) can promote proliferation of
recardiac mesodermal cells at stages prior to tubular heart
ormation (Antin et al., 1996). At later stages of cardiac
evelopment when myocyte proliferation has slowed, neu-
egulin and cardiotrophin-1 exert modest proliferative ef-
ects in vitro, but more prominent survival-promoting and
FIG. 9. Schematic representation of growth factors regulating
cardiac myocyte commitment, proliferation, and survival at dis-
tinctive developmental stages. This drawing reflects findings de-
scribed by Ladd et al. (1998); Antin et al. (1996); Zhu et al. (1996);
ima et al. (1995), this study, Zhao et al. (1998), and Wollert and
hien (1997).ypertrophic responses (Ford et al., 1999; Kuwahara et al.,
Copyright © 2000 by Academic Press. All right999; Zhao et al., 1998). Thus the sequential regulation of
ardiac myocyte commitment, proliferation, and survival/
ypertrophy may reflect myocyte responsivity to several
lasses of peptide growth factors, each utilized at a distinc-
ive developmental stage (Fig. 9).
That NT-3 may serve as a mitogen for cardiac myocytes
n the looping heart, and during the processes of trabecula-
ion and chamber formation, is supported by evidence of the
arly localization of this neurotrophin and receptor in the
eveloping heart. Although NT-3 mRNA is detectable in
arly avian embryos (HH stage 6), when heart precursors
eside in the lateral mesodermal plate, no tissue localiza-
ion has been performed to date (Zhang et al., 1996). Our
rior, limited studies in the mouse have documented trk C
rotein expression by cardiac myocytes at murine embry-
nic day 9.5, which is similar with regard to cardiac
evelopment to avian embryonic day 3 to 4 (Donovan et al.,
996). This immunohistochemical localization of trk C to
he ventricles is consistent with earlier in situ analysis in
he developing mouse embryo (Tessarollo et al., 1993).
owever, the inability to detect NT-3 and trk C mRNA at
ater stages of heart development in rats (E11–18) (Hiltunen,
996) is consistent with our observations of decreased trk C
xpression during later stages of trabecular formation at
vian E9. This dynamic regulation of both ligand and
eceptor during cardiac development and their restricted
xpression by cardiac myocytes, but not by epicardial or
ndocardial cells or cells within the endocardial cushion,
uggest that NT-3 and trk C genes may be induced by
ell-characterized cardiac transcriptional regulators (as re-
iewed by Fishman and Chien, 1997), questions amenable
o genetic dissection.
The colocalization of both ligand and receptor to cardiac
yocytes suggests an autocrine or local paracrine action of
his growth factor:receptor system. Our finding that locally
erived NT-3 acts directly on a population of rapidly
ividing cardiac myocytes is similar to that observed with
he FGFs, which colocalize with FGFR in cardiac myocytes
uring chamber formation. This contrasts with the more
omplicated expression patterns of growth factors acting at
ater developmental stages to regulate cardiac myocyte
roliferation or hypertrophy. Indeed, the expression of
ardiotrophin-1 by cardiac fibroblasts (Kuwahara et al.,
999) and neuregulins by the endocardium and microvas-
ular endothelial cells (Hertig et al., 1999; Zhao et al., 1998)
uggests that growth factors acting at later developmental
tages are subject to more complex regulatory inputs, befit-
ing a myocardium which must respond to hypoxic or
ypertensive insults.
Pleiotrophic Roles of NT-3 during Development
The biological actions of trk C on cardiac myocyte
proliferation are likely to underlie the defects on cardiac
ventricular septation and possibly those of ventricular wall
thinning observed in the NT-3- and trk C-deficient mice
(Donovan et al., 1996; Tessarollo et al., 1997). However, the
s of reproduction in any form reserved.
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190 Lin et al.trk C and NT-3 null mutant mice also exhibit defects in
valvulogenesis, outflow tract septation and rotation, and
closure of ductus arteriosus, malformations which model,
in part, the human congenital condition of Tetralogy of
Fallot. Although the molecular pathogenesis of these de-
fects in humans is still not defined, abnormalities in cardiac
neural crest as well as cardiac myocyte development have
been postulated to contribute to this complex phenotype
(Kirby, 1999). Thus it will be important in future studies to
assess whether NT-3-mediated trk C signaling could impart
additional actions upon cells of cardiac neural crest origin
to contribute to the observed abnormalities in valve and
outflow tract formation. Indeed, expression studies confirm
that trk C is expressed by trunk neural crest, and NT-3 can
promote the proliferation and differentiation of neural crest
in vitro and in vivo (Chalazonitis et al., 1998; Henion, 1995;
alcheim et al., 1992). However, further studies to directly
nhibit or augment NT-3 actions on this cell population
ill be required to evaluate the potential roles of NT-3 on
ardiac neural crest survival or migration.
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